ADMA BIOLOGICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Adma Biologics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q4 2024.
  • Adma Biologics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $112M.
  • Adma Biologics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $198M.
  • Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $198M.
  • Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$28.2M, a 57.2% increase from 2022.
  • Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$65.9M, a 8.02% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.